Literature DB >> 17716893

Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies.

Claudia Mugnaini1, Suvi Rajamaki, Cristina Tintori, Federico Corelli, Silvio Massa, Myriam Witvrouw, Zeger Debyser, Veljko Veljkovic, Maurizio Botta.   

Abstract

The identification of a novel hit compound as integrase binding inhibitor has been accomplished by means of virtual screening techniques. A small family of structurally related molecules has been synthesized and biologically evaluated with one of the compounds showing an IC(50)=12 microM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17716893     DOI: 10.1016/j.bmcl.2007.08.005

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

Review 2.  Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection.

Authors:  Jian J Tan; Xiao J Cong; Li M Hu; Cun X Wang; Lee Jia; Xing-Jie Liang
Journal:  Drug Discov Today       Date:  2010-01-22       Impact factor: 7.851

Review 3.  Simple Chemoinformatics Criterion Using Electron Donor-Acceptor Molecular Characteristics for Selection of Antibiotics Against Multi-Drug-Resistant Bacteria.

Authors:  Veljko Veljkovic; Sanja Glisic; Vladimir Perovic; Slobodan Paessler; Nevena Veljkovic; Garth L Nicolson
Journal:  Discoveries (Craiova)       Date:  2016-10-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.